Compare Paycom Software Inc (PAYC) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Paycom Software Inc vs Repligen Corporation Common Stock — how do they compare? Paycom Software Inc trades at $239 (market cap $10.77B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.31B). The key difference: Paycom Software Inc and Repligen Corporation Common Stock are close in size by market cap, and Paycom Software Inc pays a 0.63% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Paycom Software Inc for 84 Days and Repligen Corporation Common Stock for 0 Days on average.
| PAYC | RGEN | |
|---|---|---|
Market Cap | $10.77B | $11.31B |
Volume | 536,440 | 1,216,919 |
Sector | Technology | Health |
52-Week High | $240.52 | $194.57 |
52-Week Low | $113.59 | $102.87 |
Typical Hold Time | 84 Days | 0 Days |
Enterprise Value | $11.56B | $11.20B |
Dividend Yield | 0.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Paycom Software (PAYC) trades at $236.60, up 0.68% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with 22.78% net margins and consistent earnings beats, including Q2 2026 EPS of $2.78 beating expectations by 17%. Recent institutional buying and positive analyst coverage support the stock's upward trajectory despite RSI indicators suggesting potential overbought conditions.
PAYC presents growth potential with accelerating profitability and raised 2026 guidance, though current price exceeds analyst consensus target. Key risks include competitive pressures in payroll software and market volatility. The stock's premium valuation requires sustained execution to justify further upside from current levels near resistance.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Paycom Software Inc
Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
